UBS Group AG - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 55 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2018$39,000
-43.5%
163,211
-24.7%
0.00%
Q1 2018$69,000
-21.6%
216,661
+25.5%
0.00%
Q4 2017$88,000
-67.0%
172,650
-39.5%
0.00%
Q3 2017$267,000
+128.2%
285,447
+39.1%
0.00%
Q2 2017$117,000
-13.3%
205,173
-4.3%
0.00%
Q1 2017$135,000
-8.8%
214,357
+10.3%
0.00%
Q4 2016$148,000
-39.1%
194,319
+37.4%
0.00%
Q3 2016$243,000
-4.7%
141,378
-0.1%
0.00%
Q2 2016$255,000
-62.5%
141,555
-50.9%
0.00%
Q1 2016$680,000
+392.8%
288,367
+378.0%
0.00%
Q4 2015$138,000
+16.9%
60,330
+16.4%
0.00%
Q3 2015$118,000
+742.9%
51,847
+726.1%
0.00%
Q1 2015$14,000
-33.3%
6,276
-55.5%
0.00%
Q4 2014$21,00014,1060.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,734,149$6,609,00011.59%
Third Security, LLC 13,238,268$22,770,0001.06%
MSD Partners, L.P. 3,118,402$5,364,0000.43%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 290,000$499,0000.15%
BARD ASSOCIATES INC 93,299$160,0000.08%
FRANKLIN STREET ADVISORS INC /NC 126,000$217,0000.04%
BLAIR WILLIAM & CO/IL 1,998,886$3,438,0000.03%
HAMILTON LANE ADVISORS LLC 23,855$41,0000.02%
Sheaff Brock Investment Advisors, LLC 86,449$149,0000.02%
Rothschild Capital Partners, LLC 30,000$52,0000.02%
View complete list of SYNTHETIC BIOLOGICS INC shareholders